GLP-1 Microdosing, Brain Health, and Alzheimers Prevention: What the Evidence Actually Shows AI Overview GLP-1 medications such as semaglutide and tirzepatide are being studied for more than weight loss
Low energy availability can lead to Relative Energy Deficiency in Sport (RED-S), which can cause: Hormone disruption Fatigue and injuries Loss of muscle Lower performance How athletic performance takes a hit Slower recovery Poor muscle repair Blunted training adaptation Your body cannot perform efficiently when it's running on empty And the effects are not just physical, GLP-1s quiet "food noise", but can also: Dull hunger and fullness cues Reduce the enjoyment of eating Increase disconnection from your body Before considering GLP-1s, ask yourself: Am I eating enough to match the energy demands of training
Understanding your body's natural GLP-1 production provides important context for both metabolic health and the development of GLP-1-based medications
Thats my family
Though still in its infancy in GLP-1 manufacturing, R&D teams in other modalitiessuch as oligonucleotidesare already piloting this concept
Example conceptual model: While this approach has not yet been validated in large clinical trials, it reflects the idea that metabolic response may scale with body mass and lean tissue metabolism
